Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Imaging xCT with Immuno-PET in Therapy-Resistant Non-Small Cell Lung Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

A computational model to describe multi-regional brain architecture during neurodegeneration in Alzheimer's disease.

Scientific reports·2026
Same author

Illuminating proinflammatory myeloid cells with PET tracers targeting GPR84.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Metabolotheranostics of pancreatic cancer by targeting choline, glutamine, and glucose transporters with photoimmunotherapy.

Npj imaging·2026
Same author

Nanotechnology-based encapsulation of neflamapimod: A new therapeutic strategy for lewy body dementia.

Colloids and surfaces. B, Biointerfaces·2026
Same author

Semantic CT features and differentiation model: new primary lung cancer versus metastasis after previous malignancy.

European radiology·2026
Same journal

Heterometallic ludwigite M<sub>2.5</sub>T<sub>0.5</sub>(O<sub>2</sub>BO<sub>3</sub>) and (M<sub>2</sub>T)(O<sub>2</sub>BO<sub>3</sub>) (M = Co, Ni, Cu; T = Ti, Sn, Fe) compounds as electrocatalysts.

Dalton transactions (Cambridge, England : 2003)·2026
Same journal

Copper(II) complexes for electrocatalytic dioxygen reduction: controlling selectivity <i>via</i> a proton relay mode.

Dalton transactions (Cambridge, England : 2003)·2026
Same journal

Single- and tri-doping strategies with Mn<sup>2+</sup>, Sn<sup>2+</sup>, and Pb<sup>2+</sup> in cadmium-based metal halides for primary-color and tunable white-light emission.

Dalton transactions (Cambridge, England : 2003)·2026
Same journal

Heterobimetallic aluminium/group 4 complexes derived from single-electron processes initiated by an aluminyl anion.

Dalton transactions (Cambridge, England : 2003)·2026
Same journal

Thermally tunable terahertz smart window based on VO<sub>2</sub> phase change material with broadband absorption and ultra-broadband transmission.

Dalton transactions (Cambridge, England : 2003)·2026
Same journal

Cation-templated synthesis of a Fe<sub>4</sub>Co<sub>20</sub> cyanometallate cluster.

Dalton transactions (Cambridge, England : 2003)·2026
See all related articles

Related Experiment Video

Updated: May 3, 2026

Biomolecular Imaging of Cellular Uptake of Nanoparticles using Multimodal Nonlinear Optical Microscopy
07:13

Biomolecular Imaging of Cellular Uptake of Nanoparticles using Multimodal Nonlinear Optical Microscopy

Published on: May 16, 2022

1.8K

PET imaging with multimodal upconversion nanoparticles.

Juan Gallo1, Israt S Alam, Jiefu Jin

  • 1Comprehensive Cancer Imaging Centre, Department of Surgery and Cancer, Hammersmith Campus, Imperial College London, Du Cane Road, London, W12 0NN, UK. n.long@imperial.ac.uk.

Dalton Transactions (Cambridge, England : 2003)
|February 19, 2014
PubMed
Summary
This summary is machine-generated.

New upconversion nanoparticles target tumors using αvβ3 integrin. These targeted nanoparticles, functionalized with DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) for (68)Ga radiolabeling, show promise for PET cancer imaging.

More Related Videos

Multimodal Optical Imaging Platform for Studying Cellular Metabolism
04:47

Multimodal Optical Imaging Platform for Studying Cellular Metabolism

Published on: June 6, 2025

1.3K
In Vivo Optical Imaging of Brain Tumors and Arthritis Using Fluorescent SapC-DOPS Nanovesicles
09:04

In Vivo Optical Imaging of Brain Tumors and Arthritis Using Fluorescent SapC-DOPS Nanovesicles

Published on: May 2, 2014

13.2K

Related Experiment Videos

Last Updated: May 3, 2026

Biomolecular Imaging of Cellular Uptake of Nanoparticles using Multimodal Nonlinear Optical Microscopy
07:13

Biomolecular Imaging of Cellular Uptake of Nanoparticles using Multimodal Nonlinear Optical Microscopy

Published on: May 16, 2022

1.8K
Multimodal Optical Imaging Platform for Studying Cellular Metabolism
04:47

Multimodal Optical Imaging Platform for Studying Cellular Metabolism

Published on: June 6, 2025

1.3K
In Vivo Optical Imaging of Brain Tumors and Arthritis Using Fluorescent SapC-DOPS Nanovesicles
09:04

In Vivo Optical Imaging of Brain Tumors and Arthritis Using Fluorescent SapC-DOPS Nanovesicles

Published on: May 2, 2014

13.2K

Area of Science:

  • Nanotechnology
  • Radiochemistry
  • Oncology

Background:

  • Upconversion nanoparticles (UCNPs) are promising for biomedical imaging.
  • Targeting specific cancer biomarkers enhances imaging agent specificity.
  • The αvβ3 integrin is overexpressed in various cancers, including melanoma and breast cancer.

Purpose of the Study:

  • To develop novel UCNPs functionalized for tumor-specific targeting.
  • To enable radiolabeling of these UCNPs with Gallium-68 for Positron Emission Tomography (PET) imaging.
  • To evaluate the in vivo efficacy of these targeted UCNPs as cancer contrast agents.

Main Methods:

  • Synthesis of UCNPs using standard peptidic and thiol chemistry.
  • Functionalization of UCNPs with αvβ3 integrin-targeting molecules.
  • Coordination of the DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) motif for (68)Ga radiolabeling.
  • Optimization of radiolabeling conditions under mild parameters.
  • In vivo evaluation in mouse tumor models.

Main Results:

  • Successfully synthesized and functionalized UCNPs with tumor-targeting ligands.
  • Achieved efficient radiolabeling with (68)Ga under mild conditions.
  • Demonstrated specific tumor uptake and contrast enhancement in mouse models via PET imaging.
  • Highlighted the potential of these UCNPs as specific cancer contrast agents.

Conclusions:

  • Developed novel αvβ3 integrin-targeted, (68)Ga-labeled UCNPs.
  • These targeted UCNPs show significant potential for specific cancer detection using PET imaging.
  • The developed radiolabeling strategy is efficient and applicable to nanoparticulate systems.